Mutagenic Testing of Workers Exposed to Toluene-Diisocyanates during Plastics Production Process

American Journal of Industrial Medicine

Volumn 45, Issue 5, 2004, Pages 468-474

  Bilban, Marjan ^a  

^a Institute of Occupational Safety   (Slovenia)

Author keywords

Chromosomal aberrations; MN incidence; Mutagene properties; Production of plastics; SCE; Toluene diisocyanates

Indexed keywords

CARCINOGEN; TOLUENE DIISOCYANATE;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; INCIDENCE; INDUSTRIAL WORKER; MALE; MICRONUCLEUS TEST; MUTAGEN TESTING; OCCUPATIONAL EXPOSURE; PLASTIC INDUSTRY; SISTER CHROMATID EXCHANGE; STRUCTURAL CHROMOSOME ABERRATION;

ADULT; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; INDUSTRY; LYMPHOCYTES; MALE; MUTAGENICITY TESTS; OCCUPATIONAL EXPOSURE; PLASTICS; SLOVENIA; TOLUENE 2,4-DIISOCYANATE;

EID: 2342656493     PISSN: 02713586     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajim.10365     Document Type: Article

References (25)

1. American Conference of Governmental Industrial Hygienists. 2000. TLVs and BEIS. Threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati, OH.
2. Bilban M. 1998. Incidence of the work environment in a Pb-Zn mine in the incidence of cytogenetic damage in miners. Am J Ind Med 34:455-463.
3. Bilban M, Vrhovec S. 1997. Incidence of spontaneous cytogenetic changes in peripheral blood lymphocytes of a human population sample. Radiol Oncol 30:297-304.
4. Bolognesi C, Baur X, Marczynski B, Norppa H, Sepai O, Sabbioni G. 2001. Carcinogenic risk of toluene diisocyanate and 4,4 methylendiphenyl diisocyanate. Epidemiological and experimental evidence. Crit Rev Toxicol 31:737-772.
5. Dieter MP, Boorman GA, Jameson CW, Matthews HB, Huff JE. 1990. The carcinogenetic activity of commercial grade toluene diisocyanate in rats and mice in relation to the metabolism of the 2,4- and 2,6-TDI isomers. Toxicol Ind Health 6(6):599-621.
6. Doe JE, Hoffman HD. 1995. Toluene diisocyanate: An assessment of carcinogenic risk following oral and inhalation exposure. Toxicol Ind Health 11:13-32.
7. Fenech M, Morley AA. 1985. Measurement of micronuclei in lymphocytes. Mutat Res 147:29-36.
8. Foureman P, Mason JM, Valencia R, Zimmering S. 1994. Clinical mutagenesis testing in Drosophilia: X. Results of 70 coded chemicals tested for the National Toxicology Program. Environ Mol Mutagen 23(3):208-227.
9. Gulati DK, Witt K, Anderson B, Zeiger E, Shelby M. 1989. Chromosome aberration and sister chromatid exchange test in Chinese hamster ovary cells in vitro HI: Results with 27 chemicals. Environ Mol Mutagen 13(2):133-193.
10. Hagmar L, Welinder H, Mikoczy Z. 1993a. Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry; Department of Occupational and Environmental Medicine, University Hospital, Lund, Sweden. Br J Ind Med 50(6):537-543.
11. Hagmar L, Stromberg U, Welinder H, Mikoczy Z. 1993b. Incidence of cancer and exposure to toluene diisocyanate and methylene diphenyldiisocyanate: A cohort based case - Referent study in the polyurethane foam manufacturing industry; Department of Occupational and Environmental Medicine, University Hospital, Lund, Sweden. Br J Ind Med 50(11):1003-1007.
12. Holmen A, Akesson B, Hansen L, Frithiof J, Mitelman F, Karlsson A, Persson L, Welinder H, Skerfving S, Hogstedt B. 1988. Comparison among five mutagenicity assays in workers producing polyurethane foams. Int Arch Occup Environ Health 60(3):175-179.
13. IARC. 1986a. Monographs on the evaluation of the carcinogenic risk of chemicals to man. Geneva: WHO, AIRC, 1972-Present (multivolume work). V39 303 p.
14. IARC. 1986b. Monographs on the evaluation of the carcinogenic risk of chemicals to man. Geneva: WHO, AIRC, 1972-Present (multivolume work). V39 311 p.
15. IARC. 1986c. Monographs on the evaluation of the carcinogenic risk of chemicals to man. Geneva: WHO, AIRC, 1972-Present (multivolume work). V39 304 p.
16. IARC. 1999. Monographs on the evaluation of the carcinogenic risk of chemicals to man. Geneva: WHO, AIRC, 1972-Present (multivolume work). 71876 p.
17. International Atomic Energy Agency. 1986. Biological dosimetry. In: Chromosomal aberration analyses for dose assessment. Vienna: IAEA, Technical Report Series No. 260.
18. Kato H. 1974. Spontaneous sister chromatid exchange detected by BrdU-labeling method. Nature 252:70-72.
19. Loeser E. 1983. Long-term toxicity and carcinogenicity studies with 2,4-/2,6-toluene diisocyanate (80/20) in rats and mice. Toxicol Lett 15(1):71-81.
20. Maki-Paakkanen J, Norppa H. 1987. Chromosome aberrations and sister-chromatid exchange induced by technical grade toluene diisocyanate and methylendiphenyl diisocyanate in cultured human lymphocytes. Toxicol Lett 36(1):37-43.
21. Marczynski B, Czuppon AB, Marek W, Baur X. 1992. Indication of DNA strand breaks in human white blood cells after in vitro exposure to toluene diisocyanate (TDI). Toxicol Ind Health 8(3): 157-169.
22. Metelko M. 1999. Report of measurement of TDI in company XY (No. ZVD-CET 99075/A), Institute of Occupational safety Ljubljana, Slovenija.
23. Neal Benowitz L. 1997. Smoking & occupational health. In: La Dou J, editor. Occupational & environmental medicine. USA: Prentice Hall International, Inc. p 714-715.
24. Pons F, Haag M, Corocs L, Bonnet P, Guillonzo A, Lugnier A, Frossard N. 2000. Inhalation of toluene diisocyanate affects cytochrome P450 2B1 expression in rat lung. Arch Toxicol 74:397-403.
25. Wiethege T, Potthaxst J, Marczynski B, Marek W, Voss B, Baur X. 1995. Indication of rat liver foci by inhaled diisocyanate exposure. Pneumologie 49(6):373-377.